Skip to main content
SpringerLink
Log in

Current UK Practices on Health Economics Analysis Plans (HEAPs): Are We Using Heaps of Them?

  • Research letter
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abbreviations

CTU:

Clinical trials unit

HEAP:

Health economics analysis plan

RCT:

Randomised controlled trial

SOP:

Standard operating procedure

References

  1. Petrou S, Gray A. Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting. BMJ. 2011;342:d1548. https://doi.org/10.1136/bmj.d1548.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Hughes D, et al. Conducting economic evaluations alongside randomised trials: current methodological issues and novel approaches. Pharmacoeconomics. 2016;34(5):447–67.

    Article  PubMed  Google Scholar 

  3. Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A, Cook J, Glick H, Liljas B, Petitti D, Reed S. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA task force report. Value Health. 2005;8(5):521–33.

    Article  PubMed  Google Scholar 

  4. Coffman LC, Niederle M. Pre-analysis plans have limited upside, especially where replications are feasible. J Econ Respect. 2015;29(3):81–98.

    Google Scholar 

  5. Edwards RT, Hounsome B, Linck P, Russell IT. Economic evaluation alongside pragmatic randomised trials: developing a standard operating procedure for clinical trial units. Trials. 2008;9:64.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Joanna Thorn acknowledges funding from the MRC ConDuCT-II Hub (Collaboration and innovation for Difficult and Complex randomized controlled Trials in Invasive procedures—MR/K025643/1). The authors would particularly like to thank Professor Will Hollingworth and Dr. Sian Noble for their helpful comments and suggestions. This work was undertaken with the support of the MRC ConDuCT-II Hub (Collaboration and innovation for Difficult and Complex randomized controlled Trials In Invasive procedures—MR/K025643/1), and the MRC Network of Hubs for Trials Methodology Research (MR/L004933/1-N91).

Author information

Authors and Affiliations

  1. Nuffield Department of Orthopaedic Rheumatology and Musculoskeletal Sciences, Oxford Clinical Trials Research Unit, Centre for Statistics and Medicine, University of Oxford, Oxford, UK

    Melina Dritsaki, Susan Dutton & Sarah E. Lamb

  2. Nuffield Department of Population Health, Health Economics Research Centre, University of Oxford, Oxford, UK

    Alastair Gray

  3. Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK

    Stavros Petrou

  4. School of Social and Community Medicine, University of Bristol, Bristol, UK

    Joanna C. Thorn

Authors
  1. Melina Dritsaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alastair Gray
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stavros Petrou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Susan Dutton
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sarah E. Lamb
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Joanna C. Thorn
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

The concept of this paper was conceived by MD. All authors assisted in designing the survey and critically appraise the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Melina Dritsaki.

Ethics declarations

Ethics Approval and Consent to Participate

Not applicable.

Consent for Publication

Not applicable.

Availability of Data and Material

All data generated or analysed during this study are included in this published article.

Conflict of interest

The authors declare that they have no competing interests.

Funding

No funding was received.

Appendix

Appendix

See Table 2.

Table 2 Questions for the Health Economics Analysis Plans Survey
Full size table

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dritsaki, M., Gray, A., Petrou, S. et al. Current UK Practices on Health Economics Analysis Plans (HEAPs): Are We Using Heaps of Them?. PharmacoEconomics 36, 253–257 (2018). https://doi.org/10.1007/s40273-017-0598-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40273-017-0598-x

Search

Navigation